ATE534658T1 - Neue rekombinante antikoagulationsproteine - Google Patents

Neue rekombinante antikoagulationsproteine

Info

Publication number
ATE534658T1
ATE534658T1 AT03736814T AT03736814T ATE534658T1 AT E534658 T1 ATE534658 T1 AT E534658T1 AT 03736814 T AT03736814 T AT 03736814T AT 03736814 T AT03736814 T AT 03736814T AT E534658 T1 ATE534658 T1 AT E534658T1
Authority
AT
Austria
Prior art keywords
anv
kpi
methods
fusions
recombinant
Prior art date
Application number
AT03736814T
Other languages
English (en)
Inventor
Tze Chein Wun
Original Assignee
Tze Chein Wun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tze Chein Wun filed Critical Tze Chein Wun
Application granted granted Critical
Publication of ATE534658T1 publication Critical patent/ATE534658T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03736814T 2002-06-06 2003-06-04 Neue rekombinante antikoagulationsproteine ATE534658T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38693202P 2002-06-06 2002-06-06
PCT/US2003/017442 WO2003103577A2 (en) 2002-06-06 2003-06-04 Novel recombinant anticoagulant proteins

Publications (1)

Publication Number Publication Date
ATE534658T1 true ATE534658T1 (de) 2011-12-15

Family

ID=29736237

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03736814T ATE534658T1 (de) 2002-06-06 2003-06-04 Neue rekombinante antikoagulationsproteine

Country Status (8)

Country Link
US (2) US7378393B2 (de)
EP (1) EP1509541B1 (de)
JP (1) JP4444821B2 (de)
CN (1) CN1659180B (de)
AT (1) ATE534658T1 (de)
AU (1) AU2003237351B2 (de)
CA (1) CA2486362A1 (de)
WO (1) WO2003103577A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7671013B2 (en) * 2003-04-03 2010-03-02 Canadian Blood Services, Inc. Coagulation proteins, coagulation-anticoagulation protein complexes, derivatives thereof and their uses
EP1734983A4 (de) * 2004-03-11 2009-11-18 Alavita Pharmaceuticals Inc Modifizierte annexin-proteine und verfahren zur verhinderung von thrombose
US7511016B2 (en) 2004-07-07 2009-03-31 Mosamedix B.V. Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof
JP2011506590A (ja) * 2007-12-18 2011-03-03 アセラ・バイオテクノロジーズ・アーベー 血管疾患を治療するための化合物および方法
HUE035034T2 (en) 2008-02-22 2018-05-02 Annexin Pharmaceuticals Ab Compounds and methods for preventing or treating restenosis
US9192649B2 (en) 2008-10-17 2015-11-24 London Health Sciences Centre Research Inc. Annexin and its use to treat inflammatory disorders
BR112012029611A2 (pt) 2010-05-21 2017-07-25 Merrimack Pharmaceuticals Inc proteína de fusão biespecífica, composição farmacêutica, método de tratamento de dano ao tecido em um indivíduo, método de promoção da regeração ou sobrevivência do tecido em um indivíduo e molécula de ácido nucleico
EP3865147A1 (de) 2015-10-02 2021-08-18 Silver Creek Pharmaceuticals, Inc. Bispezifische therapeutische proteine zur gewebereparatur
BR102017005783A2 (pt) * 2017-03-21 2018-10-02 Fund Butantan processo de obtenção de esculptina e seus fragmentos, esculptina recombinante e seus usos
CN113956339B (zh) * 2021-10-28 2023-02-24 中国药科大学 宽体金线蛭抗凝血因子XIa多肽及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988007676A1 (en) 1987-03-27 1988-10-06 Terumo Kabushiki Kaisha Enzyme sensor
CA2276091A1 (en) * 1996-12-27 1998-07-09 Mochida Pharmaceutical Co., Ltd. Cell membrane-directed drugs

Also Published As

Publication number Publication date
WO2003103577A3 (en) 2004-03-04
EP1509541A4 (de) 2006-06-07
JP4444821B2 (ja) 2010-03-31
AU2003237351A2 (en) 2003-12-22
EP1509541B1 (de) 2011-11-23
CN1659180B (zh) 2010-06-02
WO2003103577A2 (en) 2003-12-18
AU2003237351A1 (en) 2003-12-22
AU2003237351B2 (en) 2009-12-03
CN1659180A (zh) 2005-08-24
US7378393B2 (en) 2008-05-27
EP1509541A2 (de) 2005-03-02
CA2486362A1 (en) 2003-12-18
US20050164926A1 (en) 2005-07-28
JP2005528124A (ja) 2005-09-22
US20090029444A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
Corral-Rodríguez et al. Leech-derived thrombin inhibitors: from structures to mechanisms to clinical applications
ATE534658T1 (de) Neue rekombinante antikoagulationsproteine
AR058982A1 (es) Vector de expresion de la proteina bicunina y metodo para producir dicha proteina
SE0201980D0 (sv) Novel compounds
WO2003066824A3 (en) Albumin-fused kunitz domain peptides
Lalmanach et al. Cysteine cathepsins and cystatins: from ancillary tasks to prominent status in lung diseases
DK0399666T3 (da) Fusionsproteiner indeholdende N-terminalfragmenter af human serumalbumin
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
ATE193304T1 (de) Inhibitoren der menschlichen neutrophilenelastase
ATE251176T1 (de) Intermediate zur herstellung von thrombininhibitoren als anticoagulantien
ES2062549T3 (es) Proteina anticoagulante.
WO1996035788A3 (en) Kunitz type protease inhibitors
TR199902766T2 (xx) Proteaz inhibit�rleri.
DE69025247D1 (de) Proteine mit antikoagulierenden Eigenschaften
Pereira et al. CAP 37, a 37 kD human neutrophil granule cationic protein shares homology with inflammatory proteinases
WO2004030622A3 (en) Method of isolation and self-assembly of small protein particles from blood and other biological materials
AU2003243097A1 (en) Novel compounds
Bode The structure of thrombin, a chameleon-like proteinase
Laug et al. Isolation of multiple types of plasminogen activator inhibitors from vascular smooth muscle cells
DE60132632D1 (de) Multifunktionelle protease-inhibitoren und deren verwendung zur behandlung von krankheiten
DE50105373D1 (de) Dipeptidische hemmstoffe für den gerinnungsfaktor xa
SE0203712D0 (sv) Novel compounds
WO1999063090A3 (en) Protease inhibitor peptides
ATE226591T1 (de) Oligopeptide hergeleitet von fragmenten des c- reaktiven proteins
WO2006048862A3 (en) The use of a protease or a protease inhibitor for the manufacture of medicaments